Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020:154-155:37-63.
doi: 10.1016/j.addr.2020.06.002. Epub 2020 Jun 8.

Lipid nanoparticles for nucleic acid delivery: Current perspectives

Eleni Samaridou  1 , James Heyes  1 , Peter Lutwyche  2
Affiliations
Review

Lipid nanoparticles for nucleic acid delivery: Current perspectives

Eleni Samaridou et al. Adv Drug Deliv Rev. 2020.

Abstract

Nucleic Acid (NA) based therapeutics are poised to disrupt modern medicine and augment traditional pharmaceutics in a meaningful way. However, a key challenge to advancing NA therapies into the clinical setting and on to the market is the safe and effective delivery to the target tissue and cell. Lipid Nanoparticles (LNP) have been extensively investigated and are currently the most advanced vector for the delivery of NA drugs, as evidenced by the approval of Onpattro for treatment of Amyloidosis in the US and EU in 2018. This article provides a comprehensive review of the state-of-the-art for LNP technology. We discuss key advances in the design and development of LNP, leading to a broad range of therapeutic applications. Finally, the current status of this technology in clinical trials and its future prospects are discussed.

Keywords: Gene therapy; Ionizable lipid; Lipid nanoparticles; Nucleic acid; RNA delivery; mRNA; siRNA.

PubMed Disclaimer

LinkOut - more resources